ScoreWhy is Alliance Pharma Plc ?
1
Poor Management Efficiency with a low ROCE of 9.67%
- The company has been able to generate a Return on Capital Employed (avg) of 9.67% signifying low profitability per unit of total capital (equity and debt)
2
Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.15 times
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 2.15 times
- The company has been able to generate a Return on Equity (avg) of 11.04% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Operating profit has grown by an annual rate -5.51% of over the last 5 years
4
Flat results in Dec 24
- NET PROFIT(Q) At GBP 19.65 MM has Fallen at -52.09%
- PRE-TAX PROFIT(Q) At GBP 14.64 has Fallen at -39.55%
5
Risky - Not traded in last 10 days
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 0%, its profits have fallen by -44.8%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals: Major)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Alliance Pharma Plc for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Alliance Pharma Plc
95.47%
1.92
49.74%
FTSE 100
15.94%
0.54
13.16%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.69%
EBIT Growth (5y)
-5.51%
EBIT to Interest (avg)
6.68
Debt to EBITDA (avg)
2.15
Net Debt to Equity (avg)
0.29
Sales to Capital Employed (avg)
0.44
Tax Ratio
25.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.67%
ROE (avg)
11.04%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.71
EV to EBIT
14.66
EV to EBITDA
10.93
EV to Capital Employed
1.55
EV to Sales
2.33
PEG Ratio
NA
Dividend Yield
9826.62%
ROCE (Latest)
10.59%
ROE (Latest)
12.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Alliance Pharma Plc
Cash and Eqv
Highest at GBP 32.36 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio
Lowest at 30.5 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -10.21% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Alliance Pharma Plc
Net Profit
At GBP 19.65 MM has Fallen at -52.09%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (GBP MM)
Pre-Tax Profit
At GBP 14.64 MM has Fallen at -39.55%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (GBP MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
